Given the importance of estrogen receptor (ER) status in breast cancer prognosis and management, we explored Pan-Cancer Analysis of Whole Genomes (PCAWG) data to assess whether ER status correlates with increased L1 mobilization in breast cancer.48 This evidence concerns the gene ESR1 and breast cancer.